TrialJournal of immunology (Baltimore, Md. : 1950)2021

Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.

Benjamin Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.